Gujarat Kidney and Super Speciality Intrinsic Value
Gujarat Kidney and Super Speciality (GKSL) median intrinsic value is ₹105.00 from 9 valuation models (range ₹39–₹158), vs current price ₹129.83 — -19.1% downside (Trading Above Median Value), margin of safety -23.6%. Analyse GKSL FII DII holdings to track promoter, FII and institutional holdings.
GKSL Valuation Methods Summary — DCF, Graham Number & P/E
Gujarat Kidney and Super Speciality intrinsic value across 9 models vs current price ₹129.83 — upside/downside and value range per method. For current market price and key ratios, visit Gujarat Kidney and Super Speci share price today.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹38.95 | ₹31.16 - ₹46.74 | -70.0% | EPS: ₹3.24, Sector P/E: 12x |
| Book Value Method | asset | ₹158.12 | ₹142.31 - ₹173.93 | +21.8% | Book Value/Share: ₹158.12, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹62.00 | ₹55.80 - ₹68.20 | -52.2% | Revenue/Share: ₹77.50, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹105.00 | ₹94.50 - ₹115.50 | -19.1% | EBITDA: ₹28.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹118.85 | ₹95.08 - ₹142.62 | -8.5% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹38.95 | ₹35.06 - ₹42.85 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹38.95 | ₹35.06 - ₹42.85 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹125.00 | ₹112.50 - ₹137.50 | -3.7% | ROE: 7.9%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹107.37 | ₹96.63 - ₹118.11 | -17.3% | EPS: ₹3.24, BVPS: ₹158.12 |
GKSL Intrinsic Value vs Market Price — All Valuation Models
Gujarat Kidney and Super Speciality fair value range ₹39–₹158 vs current market price ₹129.83 across 9 valuation models. Read GKSL dividend yield for the complete payout history and dividend yield track record.
GKSL Intrinsic Value Analysis — Undervalued or Overvalued?
Gujarat Kidney and Super Speciality median intrinsic value ₹105.00, current price ₹129.83 — Trading Above Median Value by 19.1%, margin of safety -23.6%.
What is the intrinsic value of GKSL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Gujarat Kidney and Super Speciality (GKSL) is ₹105.00 (median value). With the current market price of ₹129.83, this represents a -19.1% variance from our estimated fair value.
The valuation range spans from ₹38.95 to ₹158.12, indicating ₹38.95 - ₹158.12.
Is GKSL undervalued or overvalued?
Based on our multi-method analysis, Gujarat Kidney and Super Speciality (GKSL) appears to be trading above median value by approximately 19.1%.
GKSL Financial Health — Key Ratios vs Industry Benchmarks
Gujarat Kidney and Super Speciality financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 7.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 7.9% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 21.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.42x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
GKSL Cash Flow Quality — Operating & Free Cash Flow
Gujarat Kidney and Super Speciality operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹14 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |